静脉注射地尔硫控制快速心房颤动心室率疗效观察  

Effects of intravenous diltiazem for treatment of rapid ventricular rate in atrial fibrillation

作　　者：耿玉亭 

机构地区：[1]河南省禹州市人民医院心内科,禹州461670

出　　处：《临床医学》2008年第12期15-16,共2页Clinical Medicine

摘　　要：目的观察静脉注射地尔硫控制快速心房颤动(房颤)心室率的疗效及其安全性。方法66例快速房颤患者随机分为两组,治疗组34例静脉注射地尔硫,对照组32例静脉注射西地兰。结果治疗组及对照组总有效率分别为94.11%、68.75%,治疗组疗效明显优于对照组,差异有统计学意义(P<0.05)。无严重副作用发生。结论地尔硫较西地兰能更迅速、有效、安全地控制快速房颤的心室率。Objective To evaluate the effect and safety of intravenous diltiazem for treatment of rapid ventrieular rate in atrial fibrillation. Methods Sixty - six patients with rapid atrial fibrillation were divided into two groups （ the treatment group and the control group） by a single- blind . Thirty- four cases （the treatment group ） were applied by intravenous diltiazem and others by cedilanid. Results The total effective rate of the treatment group was 94.11% and the other was 68.75 % . Efficacy in the treatment group was better than that in the control group , there had significant difference （ P 〈 0. 05 ）. No serious adverse reaction happened due to dihiazem. Conclusion Diltiazem is more rapidly, effectively and safely than cedilanid in acutely slowing of rapid ventricular rate in patients with atrial fibrillation.

关 键 词：地尔硫(艹卓) 西地兰 快速心房颤动 

分 类 号：R541.75[医药卫生—心血管疾病] R541.42[医药卫生—内科学]